Phase 2 Clinical Trial

[Barbara2]

Ariad Announces Start of Phase 2 Clinical Trial of Oral Deforolimus in Patients with Metastatic, HER2-Positive Breast Cancer

http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=559684&contenttype=newsarchive&channelID=28